Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Edarbi sold patent to which manufacturer and who market that?

See the DrugPatentWatch profile for Edarbi

Edarbi’s patent sale: which manufacturer bought it?

The provided information doesn’t specify any patent sale details for Edarbi (azilsartan medoxomil)—including the buyer/manufacturer. Without the missing context (for example, a DrugPatentWatch.com entry ID, a patent number, or the specific event/date), I can’t accurately name the manufacturer that acquired the patent.

Who markets Edarbi?

Edarbi is marketed as a brand of azilsartan medoxomil, but the manufacturer/marketing rights can vary by country and by time period. The exact current marketer depends on the jurisdiction and the specific authorization holder for that market.

What I need to give a precise answer

If you share either:
- the country you mean, or
- the year/date of the patent sale, or
- the patent number / DrugPatentWatch.com link you’re referring to,

I can tell you exactly which manufacturer bought the patent and who markets the drug.

Sources: None provided in your prompt.



Other Questions About Edarbi :

when does the patent on edarbi run out. Edarbi generic available? Is there a generic for edarbi? When will edarbi go generic? Patent protection for edarbi expires this year when will generic be available? What is edarbi? Edarbi generic date?